Rogers Corporation reports developments tied to its engineered materials business, including advanced electronic materials and elastomeric materials sold for EV/HEV, automotive safety and radar systems, mobile devices, renewable energy, wireless infrastructure, energy-efficient motor drives, industrial equipment and related applications. The company manufactures in the United States, Asia and Europe and serves original equipment manufacturers and component suppliers.
Recurring Rogers news includes quarterly and annual financial results, end-market demand across industrial, electronics and communications, and automotive markets, profitability and cost-improvement initiatives, product-development commentary, capital-structure disclosures, and board or executive governance updates.
Rogers Corporation (NYSE:ROG) will release first quarter 2026 results on April 28, 2026 after market close, followed by an earnings conference call at 5:00 pm ET.
The call is hosted by Interim CEO Ali El-Haj and CFO Laura Russell. A live webcast, slide presentation, and replay will be available on Rogers' Investor Relations website.
Rogers is a global engineered materials company serving EV/HEV, automotive safety, mobile devices, renewable energy and more, with manufacturing in the US, Asia and Europe.
ScanSource (NASDAQ: SCSC) appointed Michael Webb as Senior Executive Vice President and Chief Human Resources Officer effective March 16, 2026. Webb brings over 30 years of HR and organizational development experience and will lead People & Culture, talent, recruitment, compensation, leadership development, and succession planning.
He will report to Chairman and CEO Mike Baur and previously served as Senior Vice President and Chief Administrative Officer at Rogers Corporation (NYSE: ROG).
Roche (SIX: ROG) released a global survey of 4,326 people with diabetes across 22 countries on March 5, 2026, showing large day-to-day impacts from unpredictable glucose and a strong demand for predictive tools.
Key metrics: 80% would value predictive glucose tools; 61% report diabetes as a mental burden; 71% often feel tired. Roche will present related real-world evidence at ATTD on March 11, 2026.
Rogers Corporation (NYSE:ROG) reported full-year 2025 net sales of $810.8M, gross margin of 31.7%, and a GAAP net loss of $(61.8)M. Adjusted EBITDA was $115.0M and adjusted EPS was $2.39 for 2025. Q4 2025 net sales were $201.5M with adjusted EPS of $0.89.
The company ended Q4 with $197.0M cash, reported stronger Q4 adjusted profitability versus prior year, and provided Q1 2026 guidance targeting mid-point sales growth of ~5% with notable margin improvement.
Rogers Corporation (NYSE:ROG) will announce fourth-quarter and full-year 2025 results on February 17, 2026 after market close, followed by a conference call at 5:00 PM ET.
The call will be hosted by Interim CEO Ali El-Haj with CFO Laura Russell. A live webcast, slide presentation and replay will be available on Rogers' Investor Relations website.
Rogers is a global engineered materials company serving EV/HEV, automotive, mobile devices, renewable energy and industrial markets, with manufacturing in the US, Asia and Europe.
Rogers Corporation (NYSE:ROG) reported Q3 2025 results with net sales of $216.0M, up 6.5% sequentially, and gross margin of 33.5%, up 190 basis points sequentially. GAAP diluted EPS was $0.48 and adjusted EPS was $0.90 (Q2 2025 adjusted EPS $0.34). Adjusted EBITDA was $37.2M and free cash flow was $21.2M. Ending cash totaled $167.8M. The company expects Q4 2025 net sales of $190M–$205M and adjusted EPS of $0.40–$0.80, noting typical seasonal patterns and ongoing restructuring in Europe.
Rogers Corporation (NYSE: ROG) announced that Peter Wallace will not stand for re-election at the 2026 Annual Meeting and has stepped back from the chair role while partnering on a transition.
The Board immediately elected Armand Lauzon as Chair effective October 16, 2025. The company said a search is underway to appoint a new independent director with input from activist investor Starboard Value LP. Starboard confirmed it does not intend to nominate directors for the 2026 meeting.
Rogers Corporation (NYSE:ROG) will announce third quarter 2025 results on October 29, 2025 after market close, followed by a conference call at 5:00 PM ET.
The call will be hosted by Ali El-Haj, interim president and CEO, with Laura Russell, senior vice president and CFO. A live webcast and slide presentation will be available on Rogers’ Investor Relations website at https://www.rogerscorp.com/investors, and a replay will be posted there.
Headquartered in Chandler, Arizona, Rogers supplies engineered electronic and elastomeric materials for EV/HEV, automotive safety and radar, mobile devices, renewable energy, wireless infrastructure and industrial equipment, with manufacturing in the United States, Asia and Europe.
Roche (ROG) announced on October 13, 2025 that the FDA cleared its Elecsys pTau181 blood test as the only blood-based biomarker test indicated for use in primary care to help rule out Alzheimer's-related amyloid pathology. The test is for patients aged 55 and older, was developed with Eli Lilly, and showed a 97.9% negative predictive value in a multicenter study of 312 participants reflective of a primary-care population. With > 4,500 Roche instruments already in U.S. labs and recent CE Mark/IVDR certification, Roche says the test can broaden access, improve referrals, and reduce more invasive confirmatory testing such as PET and CSF.
Rogers Corporation (NYSE:ROG) reported Q2 2025 financial results with net sales of $202.8 million, up 6.5% sequentially. The company posted a net loss of $73.6 million, primarily due to $71.8 million in non-cash impairment charges and $4.3 million in restructuring expenses. Gross margin improved to 31.6%, up 170 basis points from Q1.
Key highlights include adjusted earnings per share of $0.34, a 25.9% sequential increase, and $28 million in share repurchases. The company announced cost reduction initiatives in its AES curamik® business, expected to save over $13 million annually. For Q3 2025, Rogers projects net sales between $200-215 million and adjusted earnings per share of $0.50-0.90.